Pharmacological Priming of Adipose-Derived Stem Cells Promotes Myocardial Repair
Authors:
Open Access
- 1 January 2016
- journal article
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 64 (1) , 50-62
Abstract
Adipose-derived stem cells (ADSCs) have myocardial regeneration potential, and transplantation of these cells following myocardial infarction (MI) in animal models leads to modest improvements in cardiac function. We hypothesized that pharmacological priming of pre-transplanted ADSCs would further improve left ventricular functional recovery after MI. We previously identified a compound from a family of 3,5-disubstituted isoxazoles, ISX1, capable of activating an Nkx2-5-driven promoter construct. Here, using ADSCs, we found that ISX1 (20 mM, 4 days) triggered a robust, dose-dependent, fourfold increase in Nkx2-5 expression, an early marker of cardiac myocyte differentiation and increased ADSC viability in vitro. Co-culturing neonatal cardiomyocytes with ISX1-treated ADSCs increased early and late cardiac gene expression. Whereas ISX1 promoted ADSC differentiation toward a cardiogenic lineage, it did not elicit their complete differentiation or their differentiation into mature adipocytes, osteoblasts, or chondrocytes, suggesting that re-programming is cardiomyocyte specific. Cardiac transplantation of ADSCs improved left ventricular functional recovery following MI, a response which was significantly augmented by transplantation of ISX1- pretreated cells. Moreover, ISX1-treated and transplanted ADSCs engrafted and were detectable in the myocardium 3 weeks following MI, albeit at relatively small numbers. ISX1 treatment increased histone acetyltransferase (HAT) activity in ADSCs, which was associated with histone 3 and histone 4 acetylation. Finally, hearts transplanted with ISX1-treated ADSCs manifested significant increases in neovascularization, which may account for the improved cardiac function. These findings suggest that a strategy of drug-facilitated initiation of myocyte differentiation enhances exogenously transplanted ADSC persistence in vivo, and consequent tissue neovascularization, to improve cardiac function.Keywords
This publication has 57 references indexed in Scilit:
- Heart repair by reprogramming non-myocytes with cardiac transcription factorsNature, 2012
- Targeting Native Adult Heart Progenitors with Cardiogenic Small MoleculesACS Chemical Biology, 2012
- A small molecule differentiation inducer increases insulin production by pancreatic β cellsProceedings of the National Academy of Sciences, 2011
- Adipose Tissue-Derived Cells Improve Cardiac Function Following Myocardial InfarctionJournal of Surgical Research, 2009
- Cardiogenic small molecules that enhance myocardial repair by stem cellsProceedings of the National Academy of Sciences, 2008
- MicroRNA Regulation of Cell Lineages in Mouse and Human Embryonic Stem CellsCell Stem Cell, 2008
- Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial InfarctionJACC, 2008
- FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatasesProceedings of the National Academy of Sciences, 2007
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Stable CpG Hypomethylation of Adipogenic Promoters in Freshly Isolated, Cultured, and Differentiated Mesenchymal Stem Cells from Adipose TissueMolecular Biology of the Cell, 2006